Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

JSON

Björklund AT, Carlsten M, Sohlberg E, Liu LL, Clancy T, Karimi M, Cooley S, Miller JS, Klimkowska M, Schaffer M, Watz E, Wikström K, Blomberg P, Wahlin BE, Palma M, Hansson L, Ljungman P, Hellström-Lindberg E, Ljunggren HG, Malmberg KJ

Clin. Cancer Res. 24 (8) 1834-1844 [2018-04-15; online 2018-02-14]

Bioinformatics Support for Computational Resources [Service]

Clinical Genomics Uppsala [Service]

PubMed 29444931

DOI 10.1158/1078-0432.ccr-17-3196

Crossref 10.1158/1078-0432.ccr-17-3196